These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23150723)

  • 1. Five-year follow-up of patients with early stage breast cancer after a randomized study comparing additional treatment with viscum album (L.) extract to chemotherapy alone.
    Tröger W; Zdrale Z; Stanković N; Matijašević M
    Breast Cancer (Auckl); 2012; 6():173-80. PubMed ID: 23150723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.
    Pelzer F; Tröger W; Nat DR
    J Altern Complement Med; 2018; 24(9-10):954-961. PubMed ID: 30247950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and neutropenia in patients with early stage breast cancer: a randomized pilot study comparing additional treatment with mistletoe extract to chemotherapy alone.
    Tröger W; Jezdić S; Zdrale Z; Tišma N; Hamre HJ; Matijašević M
    Breast Cancer (Auckl); 2009 Jul; 3():35-45. PubMed ID: 21556248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival.
    Tröger W; Galun D; Reif M; Schumann A; Stanković N; Milićević M
    Eur J Cancer; 2013 Dec; 49(18):3788-97. PubMed ID: 23890767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland.
    Augustin M; Bock PR; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2005; 55(1):38-49. PubMed ID: 15727163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Follow-up of a Randomized Study of Oral Etoposide versus
    Longhi A; Cesari M; Serra M; Mariani E
    Sarcoma; 2020; 2020():8260730. PubMed ID: 32398946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Cancer Biotherapy by Viscum Album Extract Isorel: Overview of Evidence Based Medicine Findings.
    Sunjic SB; Gasparovic AC; Vukovic T; Weiss T; Weiss ES; Soldo I; Djakovic N; Zarkovic T; Zarkovic N
    Coll Antropol; 2015 Sep; 39(3):701-8. PubMed ID: 26898069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disappearance of an advanced adenomatous colon polyp after intratumoural injection with Viscum album (European mistletoe) extract: a case report.
    von Schoen-Angerer T; Goyert A; Vagedes J; Kiene H; Merckens H; Kienle GS
    J Gastrointestin Liver Dis; 2014 Dec; 23(4):449-52. PubMed ID: 25532007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Tumor-Free Survival in a Patient with Stage IV Epithelial Ovarian Cancer Undergoing High-Dose Chemotherapy and Viscum album Extract Treatment: A Case Report.
    Werthmann PG; Kempenich R; Kienle GS
    Perm J; 2018; 23():18-025. PubMed ID: 30589407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
    Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
    Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
    Grossarth-Maticek R; Ziegler R
    Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case Series.
    von Schoen-Angerer T; Wilkens J; Kienle GS; Kiene H; Vagedes J
    Perm J; 2015; 19(4):76-83. PubMed ID: 26517439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative and anticarcinogenic effects of an aqueous preparation of Abies alba and Viscum album se abies, on a L-1210 malignant cell line and tumor-bearing Wistar rats.
    Karkabounas S; Assimakopoulos D; Malamas M; Skaltsounis AL; Leonce S; Zelovitis J; Stefanou D; Evangelou A
    Anticancer Res; 2000; 20(6B):4391-5. PubMed ID: 11205277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial.
    Albain KS; Barlow WE; Ravdin PM; Farrar WB; Burton GV; Ketchel SJ; Cobau CD; Levine EG; Ingle JN; Pritchard KI; Lichter AS; Schneider DJ; Abeloff MD; Henderson IC; Muss HB; Green SJ; Lew D; Livingston RB; Martino S; Osborne CK;
    Lancet; 2009 Dec; 374(9707):2055-2063. PubMed ID: 20004966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mistletoe extract on tumor response in neoadjuvant chemoradiotherapy for rectal cancer: a cohort study.
    Baek JH; Jeon Y; Han KW; Jung DH; Kim KO
    World J Surg Oncol; 2021 Jun; 19(1):178. PubMed ID: 34130688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of real-world administration of chemotherapy and add-on Viscum album L. therapy compared to chemotherapy in the treatment of stage IV NSCLC patients.
    Thronicke A; Reinhold T; von Trott P; Grah C; Matthes B; Matthes H; Schad F
    PLoS One; 2020; 15(7):e0236426. PubMed ID: 32716969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer.
    Touboul E; Buffat L; Lefranc JP; Blondon J; Deniaud E; Mammar H; Laugier A; Schlienger M
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1019-28. PubMed ID: 8600084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
    Piccart M; van 't Veer LJ; Poncet C; Lopes Cardozo JMN; Delaloge S; Pierga JY; Vuylsteke P; Brain E; Vrijaldenhoven S; Neijenhuis PA; Causeret S; Smilde TJ; Viale G; Glas AM; Delorenzi M; Sotiriou C; Rubio IT; Kümmel S; Zoppoli G; Thompson AM; Matos E; Zaman K; Hilbers F; Fumagalli D; Ravdin P; Knox S; Tryfonidis K; Peric A; Meulemans B; Bogaerts J; Cardoso F; Rutgers EJT
    Lancet Oncol; 2021 Apr; 22(4):476-488. PubMed ID: 33721561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.